Interestingly, methylated FOXK2 has been observed in circulating leukocytes of smokers in an epigenome-wide association study of nicotine equivalents (23), suggesting that epigenetic modifications serve as additional mechanisms for silencing FOXK2 gene expression, which may have implications for the pathogenesis of lung cancer. Here, FOXK2 is linked to lung carcinoma.